New immune drug PHST001 enters first human trials for Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase trial is testing a new drug called PHST001, which helps the immune system attack cancer cells by blocking a protein called CD24. The study will first test PHST001 alone, then in combination with standard chemotherapy, in adults with advanced solid tumors (includi…
Phase: PHASE1 • Sponsor: Pheast Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC